Neuropace, Inc. - Common Stock — Cash Flow (NASDAQ:NPCE) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -24.58 M-36.87 M-19.7 M-17.95 M-11.01 M -9.42 M Cash from investing activities -85.4 M23.8 M23.03 M8.99 M-332 K -412 K Cash from financing activities 102.53 M490 K8.13 M4.33 M19.6 M -1.67 M Free cash flow -24.58 M-36.87 M-19.7 M-17.95 M-11.34 M -9.84 M

News

Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?

NPCE Explains How NeuroPace's RNS System Makes Money

NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care

NPCE Stock Gains on Q1 Earnings & Revenue Beat, 2026 Outlook Raised

NeuroPace, Inc. (NPCE) Q1 2026 Earnings Call Transcript

NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates

BSX Q1 Neuromodulation Sales Rise 15% Y/Y: What Lies Behind the Growth?

NeuroPace (NPCE) Moves 6.3% Higher: Will This Strength Last?

Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026

NPCE RNS System Explained: Growth Drivers and Setup for 2026

NeuroPace's Seizure ID and New Indication Could Expand RNS Demand

Neuropace (NPCE) chief medical officer sells $399k in stock